A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Phase 2CompletedNCT00821002

Mati Therapeutics Inc.32 enrolled

Overview

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Open-Angle Glaucoma Ocular Hypertension

Interventions

LatanoprostDRUG

Comparison of punctal plug placement between upper and lower puncta

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Over 18 years * Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension Exclusion Criteria: * Uncontrolled medical conditions * Subjects who wear contact lenses * Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications

Locations (1)

Unnamed facility

Menlo Park, California, United States

Outcomes

Primary Outcomes

Intraocular pressure change from baseline (mmHg)

Time frame: 6 weeks

Secondary Outcomes

Number of subjects with adverse events

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.